Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Oct 03 2022

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-oct-03-2022-3

Zydus Lifesciences Limited has informed the Exchange about press release dated 03-Oct-2022 titled Zydus receives final approval from USFDA and 180 days shared exclusivity for Mirabegron Extended-Release Tablets 3.10.22

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases